- MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61
Mahsa Zarei et al, 2021, Oncogene CrossRef - Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells
Mustafa Ilhan et al, 2020, European Journal of Cell Biology CrossRef - Serum CYR61 as a potential biomarker to improve breast cancer diagnostics
Zhen Lin et al, 2022, Biomarkers in Medicine CrossRef - Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells
Ingrid Espinoza et al, 2022, Aging CrossRef - Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
Feilun Cui et al, 2018, The Prostate CrossRef - RU486 Metabolite Inhibits CCN1/Cyr61 Secretion by MDA-MB-231-Endothelial Adhesion
Suhong Yu et al, 2019, Frontiers in Pharmacology CrossRef - An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
Gabrielle J. Dardis et al, 2023, iScience CrossRef